IASLC lauds FDA approval of alectinib for lung cancer treatment

[News]

The International Association for the Study of Lung Cancer (IASLC) is once again gratified to see the approval of a new second-generation lung cancer treatment that can help many patients in their battle against the disease.

More... (http://www.news-medical.net/news/20151224/IASLC-lauds-FDA-approval-of-alectinib-for-lung-cancer-treatment.aspx)